Alnylam Pharmaceuticals Honored with 2024 Tell Award for Its Impactful Investments in Switzerland#United_States#New_York#Switzerland#Alnylam_Pharmaceuticals#Tell_Award
Alnylam Pharmaceuticals Honored with 2024 Tell Award for Its Impactful Investments in Switzerland
Alnylam Pharmaceuticals, a leading biotech firm from the U.S., has been awarded the 2024 Tell Award for its significant investments in Switzerland, showcasing strong U.S.-Swiss business relations.
third-news.com
January 23, 2025 at 5:44 PM
Alnylam Pharmaceuticals Honored with 2024 Tell Award for Its Impactful Investments in Switzerland#United_States#New_York#Switzerland#Alnylam_Pharmaceuticals#Tell_Award